DES daughters with rare cancer 'face high death rates'

Women who were exposed to the synthetic oestrogen diethylstilbestrol (DES) in utero, and who subsequently developed a rare type of vaginal and cervical cancer, continue to face a higher rate of death between the ages of 35 and 65, according to research.

Dr Dezheng Huo, of the University of Chicago department of medicine, and colleagues found that for DES-exposed women diagnosed with clear cell adenocarcinoma (CCA), the death rate from all causes was five times higher at ages 35 to 49 and twice as high for women 50 to 65, compared to unexposed women in the same age groups.

"We found that

Latest